This page can be referred to using the following tiny url: http://tinyurl.com/czn526l
National Institute for Health and Clinical Excellence (NICE)
|Subject Keywords:||Hepatitis testing, Treatment services|
This guidance aims to ensure more people at increased risk of hepatitis B and C infection are tested.
The guidance is for commissioners and providers of public health services, hepatitis testing and treatment services and laboratory services for hepatitis B and C testing. It is also for local organisations providing services for children and adults at increased risk of hepatitis B and C infection, including those in the NHS, local authorities, prisons, immigration removal centres and drugs services, and for voluntary sector and community organisations working with people at increased risk.
The guidance may also be of interest to groups at increased risk of viral hepatitis, for example, migrant populations from countries with an intermediate or high prevalence of hepatitis B or hepatitis C infection or people who inject drugs and their families. In addition, other members of the public may have an interest in this guidance.
The guidance does not provide detailed recommendations on treatments for hepatitis B or C. Existing guidance on management of hepatitis B and C, and on hepatitis B vaccination, is highlighted.
National Institute for Health and Clinical Excellence (NICE). (2012) Hepatitis B and C: ways to promote and offer testing to people at increased risk of infection (PH 43) [Online]. Available from: http://www.thehealthwell.info/node/410725 [Accessed: 20th February 2017].
Altmetrics are currently not available for this resource.